- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00935909
Use of Vein Viewer for Insertion of Peripheral Venous Cannula in Pediatric Patients With Difficult Intravenous Access
June 19, 2013 updated by: Peter Szmuk
Use of Vein Viewer for Insertion of Peripheral Venous Cannula in Pediatric Patients With Difficult Intravenous Access.
The primary purpose of this prospective, randomized trial is successful intravenous (IV) cannulation on first attempt with the use of either the Vein Viewer (VV) or standard cannulation method.
The secondary purpose is to find out if there is a difference in the total time to successful cannulation.
Study Overview
Status
Completed
Conditions
Detailed Description
A single initial data page will be filled out by one of the study team members present with the IV Team at the time of the cannulation.
The data from these forms will be entered by the investigator or research assistant into a database maintained only for this study.
There will be two groups in this randomized study.
One group will receive IV cannulation with the VV and the second group will receive standard cannulation without the VV.
The chance of receiving either treatment is based on randomly generated computer codes, unknown by the IV team.
We want to evaluate successful IV cannulation on first attempt as well as the time taken for cannulation.
All documents will be de-identified of data that contains HIPAA protected health information (PHI) at the end of the study.
We estimate approximate enrollment to be 790 children.
The study is expected to last 12 months and will only be conducted at Children's Medical Center Dallas.
Study Type
Observational
Enrollment (Actual)
603
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75235
- Children's Medical Center Dallas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
The floor patients meeting the inclusion/exclusion criteria that need an IV
Description
Inclusion Criteria:
- Patients age 0-18 requiring IV cannula (ASA 1-4) with a modified DIVA score ≥ 2 at the time of assessment
Exclusion Criteria:
- Patients with visible veins will be excluded from the study as well as patients with known difficult IV access which are scheduled for PICC line placement.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Successful IV cannulation on the first attempt
Time Frame: Time of cannulation will be measured from the application of the tourniquet until successful IV cannulation.
|
Time of cannulation will be measured from the application of the tourniquet until successful IV cannulation.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total time to successful IV cannulation
Time Frame: Time of cannulation will be measured from the application of the tourniquet until successful IV cannulation.
|
Time of cannulation will be measured from the application of the tourniquet until successful IV cannulation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Peter Szmuk, MD, UT Southwestern
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (Actual)
July 1, 2010
Study Completion (Actual)
July 1, 2010
Study Registration Dates
First Submitted
July 2, 2009
First Submitted That Met QC Criteria
July 8, 2009
First Posted (Estimate)
July 9, 2009
Study Record Updates
Last Update Posted (Estimate)
June 21, 2013
Last Update Submitted That Met QC Criteria
June 19, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 112008-014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on IV Cannulation
-
St. Jude Children's Research HospitalCompletedCannulationUnited States
-
Ankara UniversityBengi Safak; Ahmet Onat Bermede; Ayşegül GüvenCompletedCatheterization | CannulationTurkey
-
Alexandria UniversityUnknownIntravenous CannulationEgypt
-
The Hospital for Sick ChildrenCompleted
-
National Taiwan University HospitalNational Taiwan University Hospital Bei-Hu BranchRecruitingSuccessful CannulationTaiwan
-
Société Française d'Endoscopie DigestiveCompletedCatheterization | Biliary Cannulation | Cholangiopancreatography | Endoscopic Retrograde Cholangiography | Difficult Biliary Cannulation | Double-guidewire TechniqueFrance
-
Kasr El Aini HospitalRecruiting
-
Mahidol UniversityEnrolling by invitationRadial Artery CannulationThailand
-
Tribhuvan University Teaching Hospital, Institute...Completed
-
Clear Guide MedicalChildren's National Research InstituteCompletedCentral Vein CannulationUnited States